<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0"><channel><title>Blogs</title><link>https://www.morganlewis.com/rss/blogs</link><description>Blogs RSS Feed</description><count>25</count><item><link>https://www.morganlewis.com/blogs/healthlawscan/2026/06/cms-proposes-significant-limits-on-medicaid-state-directed-payments</link><title>CMS Proposes Significant Limits on Medicaid State Directed Payments</title><description>The Centers for Medicare &amp; Medicaid Services (CMS) issued a proposed rule that would significantly limit Medicaid managed care State Directed Payments (SDPs) and certain fee-for-service payments. These changes seek to implement, and go well beyond, the relevant directives under the Working Families Tax Cut legislation (also known as the One Big Beautiful Bill Act).</description><pubDate>Thu, 11 Jun 2026 00:00:00 -0500</pubDate><body></body><guid>e1f08060-fe4c-464a-9a50-cb046ec08702</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Litigation, Regulation &amp;amp; Investigations</practice><practice>United States</practice><practice>Healthcare</practice><practice>Hospitals, Health Systems &amp; Academic Medical Centers</practice><PGcodes>FDA</PGcodes><PGcodes>LIT</PGcodes><author>Gregory N. Etzel</author><author>B. Scott McBride</author><author>Tesch Leigh West</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2026/05/doj-forms-west-coast-strike-force-to-combat-health-care-fraud</link><title>DOJ Forms West Coast Strike Force to Combat Health Care Fraud</title><description>The US Department of Justice (DOJ) has announced a significant expansion of its health care fraud enforcement efforts with the formation of the West Coast Health Care Fraud Strike Force. This initiative is spearheaded by the newly created National Fraud Enforcement Division of DOJ, established by President Trump via executive order in January 2026 and led by recently confirmed Assistant Attorney General (AG) for Fraud Colin McDonald.</description><pubDate>Thu, 28 May 2026 00:00:00 -0500</pubDate><body></body><guid>5d7cf9cd-09e0-452b-bd63-a14d52f178ab</guid><practice>Litigation, Regulation &amp;amp; Investigations</practice><practice>FDA &amp;amp; Healthcare</practice><practice>White Collar Litigation &amp;amp; Government Investigations</practice><practice>United States</practice><practice>Healthcare</practice><practice>Hospitals, Health Systems &amp; Academic Medical Centers</practice><practice>Hospice &amp; Homecare</practice><practice>Long-Term &amp; Post-Acute Care</practice><PGcodes>LIT</PGcodes><PGcodes>FDA</PGcodes><author>Howard J. Young</author><author>Sandra Moser</author><author>Rachel L. Lamparelli</author><author>Sydney Menack</author><author>Jonathan P. York</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2026/05/key-takeaways-from-the-boston-bar-associations-white-collar-crime-conference</link><title>Key Takeaways from the Boston Bar Association’s White Collar Crime Conference</title><description>The Boston Bar Association held its annual White Collar Crime Conference on May 7, 2026, featuring lawyers from the defense and plaintiffs’ bar and current and former prosecutors from the US Attorney’s Office for the District of Massachusetts (the Office) and the Office of the Massachusetts Attorney General.</description><pubDate>Thu, 21 May 2026 00:00:00 -0500</pubDate><body></body><guid>8d39acf8-61b0-4b10-8b37-4a4f84f70b70</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Litigation, Regulation &amp;amp; Investigations</practice><practice>United States</practice><practice>Life Sciences</practice><practice>Pharmaceuticals &amp; Biotechnology</practice><practice>Healthcare</practice><practice>Hospitals, Health Systems &amp; Academic Medical Centers</practice><practice>Retail &amp; Specialty Pharmacies</practice><practice>Insurance</practice><practice>Health &amp; Long-Term Care Insurance</practice><PGcodes>FDA</PGcodes><PGcodes>LIT</PGcodes><author>Jonathan P. York</author><author>Scott A. Memmott</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2026/05/doj-unveils-focus-initiative-prioritizing-data-miner-fca-cases</link><title>DOJ Unveils FOCUS Initiative Prioritizing Data Miner FCA Cases</title><description>The DOJ recently announced the Fraud Oversight through Careful Use of Statistics (FOCUS) initiative to address the growing number of False Claims Act (FCA) qui tam complaints filed by “data miners,” defined as individuals or organizations that use publicly available government data rather than traditional insider information to identify patterns that may indicate fraud.</description><pubDate>Tue, 19 May 2026 00:00:00 -0500</pubDate><body></body><guid>0dae3cf7-4ac9-4fdf-a6b3-5105452a0e12</guid><practice>Litigation, Regulation &amp;amp; Investigations</practice><practice>FDA &amp;amp; Healthcare</practice><practice>United States</practice><practice>Healthcare</practice><practice>Hospitals, Health Systems &amp; Academic Medical Centers</practice><PGcodes>LIT</PGcodes><PGcodes>FDA</PGcodes><author>B. Scott McBride</author><author>Rachel L. Lamparelli</author><author>Sydney Menack</author><author>Jonathan P. York</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2026/05/cms-imposes-six-month-nationwide-hospice-and-home-health-medicare-enrollment-moratorium-effective-may-13</link><title>CMS Imposes Six-Month Nationwide Hospice and Home Health Medicare Enrollment Moratorium Effective May 13</title><description>The Centers for Medicare &amp; Medicaid Services (CMS) on May 13, 2026 announced a nationwide temporary moratorium on new Medicare enrollments for hospices and home health agencies, representing a significant escalation in the agency’s use of front-end program integrity tools. The moratorium applies across all states and is effective immediately, with an initial duration of six months and the potential for extension.</description><pubDate>Thu, 14 May 2026 00:00:00 -0500</pubDate><body></body><guid>c97fc79b-7aaa-4b44-abde-cc190a806114</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Litigation, Regulation &amp;amp; Investigations</practice><practice>United States</practice><practice>Healthcare</practice><practice>Hospice &amp; Homecare</practice><practice>Long-Term &amp; Post-Acute Care</practice><PGcodes>FDA</PGcodes><PGcodes>LIT</PGcodes><author>Howard J. Young</author><author>Roshni Edalur</author><author>Rachel L. Lamparelli</author><author>Jonathan P. York</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2026/04/major-government-updates-from-ahla-medicare-and-medicaid-conference</link><title>Major Government Updates from AHLA Medicare and Medicaid Conference</title><description>From March 18–20, 2026, the American Health Law Association (AHLA) hosted its annual Institute on Medicare and Medicaid Payment Issues conference in Baltimore, Maryland, focused on the full range of risks and opportunities relating to participation in federal health care payment programs. The schedule provided a formal blueprint for addressing updates in Medicare Parts A &amp; B, Medicaid program changes, supplemental payments, cost reporting, appeals, fraud and abuse, compliance obligations, and health equity requirements. Partners Scott McBride and Greg Etzel made presentations on the underpinnings of overpayments and on Medicare cost reporting and appeals, respectively.</description><pubDate>Thu, 02 Apr 2026 00:00:00 -0500</pubDate><body></body><guid>a6cf5039-4efc-45ba-8603-ba81eb3f0168</guid><practice>United States</practice><practice>Healthcare</practice><author>Tesch Leigh West</author><author>Gregory N. Etzel</author><author>B. Scott McBride</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2026/02/favorable-oig-advisory-opinion-underscores-ongoing-scrutiny-of-ancillary-service-referrals</link><title>Favorable OIG Advisory Opinion Underscores Ongoing Scrutiny of Ancillary Service Referrals</title><description>The US Department of Health and Human Services Office of Inspector General (OIG) recently issued Advisory Opinion No. 26-02, concluding that a proposed arrangement under which an urgent care management entity would operate an affiliated clinical laboratory would not generate prohibited remuneration under the federal Anti-Kickback Statute.</description><pubDate>Thu, 26 Feb 2026 00:00:00 -0600</pubDate><body></body><guid>5737d0e4-dabe-41bb-aaef-9d5241b451fd</guid><practice>FDA &amp;amp; Healthcare</practice><practice>United States</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><author>B. Scott McBride</author><author>Albert W. Shay</author><author>Jeanna Palmer Gunville</author><author>Sydney Menack</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2026/02/virtual-direct-supervision-allowed-for-incident-to-medicare-billing-and-other-telehealth-updates</link><title>Virtual Direct Supervision Allowed for ‘Incident to’ Medicare Billing and Other Telehealth Updates</title><description>The Centers for Medicare &amp; Medicaid Services (CMS) allows the use of real-time, two-way audio/video communications technology to satisfy the direct supervision requirement for most Medicare Part B services. This development, stemming from flexibilities first introduced during the COVID-19 public health emergency, is now permanent. Additionally, the Consolidated Appropriations Act, 2026 extended and permanently implemented certain Medicare telehealth flexibilities.</description><pubDate>Thu, 12 Feb 2026 00:00:00 -0600</pubDate><body></body><guid>45ae2b83-5751-49d1-adef-0f3a3c050f3b</guid><practice>FDA &amp;amp; Healthcare</practice><practice>United States</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><author>Tesch Leigh West</author><author>Gregory N. Etzel</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2026/02/medicare-advantage-agent-and-broker-agreements-2025-in-review</link><title>Medicare Advantage Agent and Broker Agreements: 2025 in Review</title><description>2025 was an important year for Medicare Advantage (MA) plans that pay state-licensed agents and brokers to market their plans and engage in lead generation, subject to complex federal regulations. As we previously discussed on  Health Law Scan , improper broker arrangements were identified as a 2025 focus area by the whistleblower bar and the US Department of Justice (DOJ), particularly the US Attorney’s Office for the District of Massachusetts.</description><pubDate>Fri, 06 Feb 2026 00:00:00 -0600</pubDate><body></body><guid>b6fc83e6-53c1-4fdc-8dea-98f25d7dd279</guid><practice>United States</practice><practice>Healthcare</practice><author>Tesch Leigh West</author><author>Scott A. Memmott</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2026/01/cms-expands-hospice-oversight-to-georgia-and-ohio-as-dea-extends-telemedicine-flexibilities</link><title>CMS Expands Hospice Oversight to Georgia and Ohio as DEA Extends Telemedicine Flexibilities</title><description>Recent regulatory actions by the Centers for Medicare and Medicaid Services (CMS), the US Drug Enforcement Administration (DEA), and the US Department of Health and Human Services (HHS) highlight heightened federal scrutiny of hospice providers in higher-risk states and continued uncertainty about the future regulation of controlled substance prescribing.</description><pubDate>Mon, 12 Jan 2026 00:00:00 -0600</pubDate><body></body><guid>4c7f6f50-a487-4a3a-acab-9155c8b72358</guid><practice>Healthcare Transactions</practice><practice>FDA &amp;amp; Healthcare</practice><practice>Healthcare &amp;amp; Life Sciences Litigation</practice><practice>United States</practice><practice>Healthcare</practice><practice>Life Sciences</practice><practice>Digital Health</practice><PGcodes>FDA</PGcodes><author>Howard J. Young</author><author>Roshni Edalur</author><author>Rachel L. Lamparelli</author><author>Jonathan P. York</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/11/applied-behavioral-analysis-key-service-for-children-with-autism-is-under-payment-scrutiny</link><title>Applied Behavioral Analysis: Key Service for Children with Autism Is Under Payment Scrutiny</title><description>In the past decade, there has been a significant increase in the utilization of Applied Behavioral Analysis (ABA) therapy, in large part because of expanded coverage under all Medicaid programs since 2022. Both federal and state regulators and enforcement authorities have turned their attention to the coverage and payment of these ABA services and potential fraud and abuse. This blog provides some quick takeaways for stakeholders.</description><pubDate>Fri, 14 Nov 2025 00:00:00 -0600</pubDate><body></body><guid>5bb5b93b-8c3c-47f6-9926-d0adc30e171a</guid><practice>FDA &amp;amp; Healthcare</practice><practice>United States</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><author>Howard J. Young</author><author>Tesch Leigh West</author><author>Jonathan P. York</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/10/double-dose-of-regulation-the-impact-of-sb-351-and-ab-1415-on-california-healthcare-transactions</link><title>Double Dose of Regulation: The Impact of SB 351 and AB 1415 on California Healthcare Transactions</title><description>California Governor Gavin Newsom recently signed two new bills into law that formalize restrictions on medical and dental practice management platforms operated by private equity groups and hedge funds and increase the state’s oversight of certain healthcare transactions. SB 351 and AB 1415 reflect California’s increasing attention on private equity and hedge fund participation in the healthcare industry. The changes to the law under each bill will go into effect on January 1, 2026.</description><pubDate>Tue, 28 Oct 2025 00:00:00 -0500</pubDate><body></body><guid>563f6dc1-7d9e-4d7a-a12d-d3fbf34acbab</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Healthcare Transactions</practice><practice>Mergers &amp;amp; Acquisitions</practice><practice>Private Equity</practice><practice>Antitrust &amp;amp; Competition</practice><practice>Healthcare</practice><practice>Healthcare Private Equity &amp; Strategic Transactions</practice><PGcodes>FDA</PGcodes><PGcodes>CBT</PGcodes><PGcodes>MA</PGcodes><PGcodes>PE</PGcodes><PGcodes>ATR</PGcodes><author>Jeanna Palmer Gunville</author><author>Qian (Susan) Zhu</author><author>Rachel L. Lamparelli</author><author>Sydney Menack</author><author>Y. Frank Ren</author><author>Sydney Reed Swanson</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/10/remote-control-key-findings-and-implications-of-hhs-oigs-report-on-medicare-billing-for-rpm</link><title>Remote Control: Key Findings and Implications of HHS-OIG’s Report on Medicare Billing for RPM</title><description>The US Health and Human Services Office of Inspector General (OIG) recently released a report by its Office of Evaluation and Inspections highlighting significant trends and recommendations regarding billing for remote patient monitoring (RPM) in Medicare. The report acknowledges the growing adoption of RPM as a technology-based healthcare service while underscoring the importance of providers and the Medicare program adopting compliance-oriented safeguards when billing and paying for RPM services.</description><pubDate>Tue, 21 Oct 2025 00:00:00 -0500</pubDate><body></body><guid>018029fb-83c6-4f1e-be7a-238f436fbaab</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><author>Howard J. Young</author><author>Rachel L. Lamparelli</author><author>Roshni Edalur</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/10/enforcement-notes-from-american-health-law-associations-fraud-and-compliance-forum</link><title>Enforcement Notes from American Health Law Association’s Fraud and Compliance Forum</title><description>Representatives from the defense bar and the healthcare and life sciences industry recently met for the American Health Law Association’s Fraud and Compliance Forum. The conference programming covered an array of topics for practitioners, ranging from the practical risks of and guidance for using artificial intelligence (AI) in clinical operations to discussions of commercial reasonableness and fair market value in compensation.</description><pubDate>Thu, 16 Oct 2025 00:00:00 -0500</pubDate><body></body><guid>f99cee2a-1054-45de-b3f1-26168f6721e5</guid><practice>FDA &amp;amp; Healthcare</practice><practice>United States</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><author>Jonathan P. York</author><author>B. Scott McBride</author><author>Scott A. Memmott</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/08/ninth-circuit-ruling-confirms-strength-of-the-eliminating-kickbacks-in-recovery-act</link><title>Ninth Circuit Ruling Confirms Strength of the Eliminating Kickbacks in Recovery Act</title><description>Since its enactment in 2018, the Eliminating Kickbacks in Recovery Act (EKRA) has rapidly gained momentum as a powerful tool against healthcare kickbacks. By 2020, the US Department of Justice (DOJ) had already secured its first EKRA conviction. This relatively young law, aimed at curbing patient brokering in laboratories, recovery centers, and treatment facilities, carries hefty penalties and, unlike older statutes, applies even to services billed to private insurance.</description><pubDate>Wed, 06 Aug 2025 00:00:00 -0500</pubDate><body></body><guid>43c089f3-1d9c-4d07-81a9-b324cabafc4a</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Life Sciences Transactions</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><PGcodes>LS</PGcodes><author>Scott A. Memmott</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/07/oigs-advisory-opinion-no-25-08-negative-opinion-highlights-potential-broad-reach-of-aks</link><title>OIG’s Advisory Opinion No. 25-08: Negative Opinion Highlights Potential Broad Reach of AKS</title><description>In a relatively rare move, the US Department of Health and Human Services Office of Inspector General (OIG) recently issued an unfavorable Advisory Opinion (No. 25-08) (Opinion) reinforcing the agency’s expansive view of the federal Anti-Kickback Statute (AKS).</description><pubDate>Thu, 31 Jul 2025 00:00:00 -0500</pubDate><body></body><guid>15070886-e6bc-4bbf-87ab-f61777f78104</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><author>Jonathan P. York</author><author>Rachel L. Lamparelli</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/05/mass-usao-focuses-on-healthcare-fraud-in-private-equity-investments-broker-arrangements-at-annual-conference</link><title>Mass. USAO Focuses on Healthcare Fraud in Private Equity Investments, Broker Arrangements at Annual Conference</title><description>On May 8, 2025, the Boston Bar Association hosted its annual White Collar Crime Conference, a reoccurring theme of which was the recognition of changing times, while also maintaining that the core principles of criminal and civil fraud enforcement remain the same. An anticipated highlight from the conference came from the panel addressing federal and state False Claims Act (FCA) and Anti-Kickback Statute (AKS) enforcement priorities.</description><pubDate>Mon, 19 May 2025 00:00:00 -0500</pubDate><body></body><guid>e2368a27-8ff6-40c9-b592-f620cd48781d</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Healthcare</practice><practice>Life Sciences</practice><practice>Pharmaceuticals &amp; Biotechnology</practice><practice>Medical Devices</practice><PGcodes>FDA</PGcodes><author>Tesch Leigh West</author><author>Scott A. Memmott</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/04/courts-diverge-in-challenges-to-cmss-minimum-staffing-requirements-for-ltc-facilities</link><title>Courts Diverge in Challenges to CMS's Minimum Staffing Requirements for LTC Facilities</title><description>On May 10, 2024, the Centers for Medicare and Medicaid Services (CMS) published its Final Rule to implement minimum staffing standards for long-term care (LTC) facilities in the United States. However, as discussed in our prior blog post, the Final Rule was immediately challenged under the Administrative Procedure Act (APA) in two major lawsuits. These cases have resulted in divergent rulings, injecting more uncertainty across the LTC industry about the future of the application and validity of the Final Rule.</description><pubDate>Tue, 29 Apr 2025 00:00:00 -0500</pubDate><body></body><guid>fc03f748-f3da-40dc-91a6-4cd846ae3f50</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><author>Jonathan P. York</author><author>Sydney Menack</author><author>Howard J. Young</author><author>Scott A. Memmott</author><author>Kayla Stachniak Kaplan </author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/02/hhs-oig-sets-out-limited-guardrails-for-patient-assistance-arrangements</link><title>HHS OIG Sets Out Limited Guardrails for Patient Assistance Arrangements</title><description>In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on  As Prescribed  and  Health Law Scan , focusing on issues impacting the rare disease community.</description><pubDate>Tue, 04 Feb 2025 00:00:00 -0600</pubDate><body></body><guid>eea1cbd2-c40b-4cdc-b759-3061613e38c1</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Healthcare</practice><practice>Life Sciences</practice><PGcodes>FDA</PGcodes><author>Scott A. Memmott</author><author>Jonathan P. York</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/01/affordable-care-act-section-1557-new-language-accessibility-requirements</link><title>Affordable Care Act Section 1557: New Language Accessibility Requirements</title><description>Section 1557 of the Affordable Care Act (ACA) prohibits discrimination on the basis of race, color, national origin, sex, age, or disability in certain healthcare activities. Among other requirements, all healthcare providers that receive, directly or indirectly, federal financial assistance, including but not limited to participation in Medicare or Medicaid must now provide a notice of availability of language assistance services free of charge. The US Department of Health and Human Services’ (HHS) new set of requirements was finalized in April 2024.</description><pubDate>Thu, 30 Jan 2025 00:00:00 -0600</pubDate><body></body><guid>835a8ac3-9a73-4574-82de-5dd91a40ba5e</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><author>Amy M. Magnano</author><author>Michael J. Madderra</author><author>Roshni Edalur</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2025/01/trump-executive-order-signals-drug-pricing-reforms-likely-on-the-horizon</link><title>Trump Executive Order Signals Drug Pricing Reforms Likely on the Horizon</title><description>Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle drug pricing reforms over the next four years. However, Biden-era policies are likely to limit a comprehensive overhaul of existing reforms in the near term.</description><pubDate>Tue, 28 Jan 2025 00:00:00 -0600</pubDate><body></body><guid>b89237e1-e718-4d98-945c-5d92769f98ce</guid><practice>FDA &amp;amp; Healthcare</practice><PGcodes>FDA</PGcodes><author>Rachel L. Lamparelli</author><author>Sydney Menack</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2024/12/2024-year-end-recap-of-california-consumer-privacy-act-activity</link><title>2024 Year-End Recap of California Consumer Privacy Act Activity</title><description>First passed into law in 2018, the California Consumer Privacy Act (CCPA) received its first major update in 2020 by way of the California Privacy Rights Act (CPRA), through which the California Privacy Protection Agency (CPPA) was established. Now, in 2024, the CPPA and California Attorney General (AGO) have swung into action with advisory and enforcement activity.</description><pubDate>Mon, 30 Dec 2024 00:00:00 -0600</pubDate><body></body><guid>e96a2a01-78fb-412a-a822-a7108f41c202</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Cybersecurity, Incident Response &amp; Privacy</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><PGcodes>ACCP</PGcodes><PGcodes>LIT</PGcodes><author>Michael J. Madderra</author><author>Kristin M. Hadgis</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2024/12/congress-temporarily-extends-hospice-telehealth-face-to-face-flexibility</link><title>Congress Temporarily Extends Hospice Telehealth Face-to-Face Flexibility</title><description>US Congress on December 20, 2024 passed a last-minute temporary government funding bill that keeps the government open for three months. As part of this package, a number of existing telehealth flexibilities were also extended to March 31, 2025. This includes the flexibility permitting the use of audio/video telehealth technologies to conduct hospice face-to-face visits, which many hospices and their physicians and nurse practitioners have come to rely upon since Medicare allowed that flexibility during the COVID public health emergency.</description><pubDate>Tue, 24 Dec 2024 00:00:00 -0600</pubDate><body></body><guid>d55f3cf1-cc45-4e46-8301-d99ea6a9e668</guid><practice>Healthcare</practice><author>Howard J. Young</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2024/11/falling-star-ratings-in-medicare-advantage-lead-to-meteoric-payment-losses</link><title>Falling Star Ratings in Medicare Advantage Lead to Meteoric Payment Losses</title><description>The enormous impact of Medicare Star Ratings on payments received by Medicare Advantage plans cannot be overstated. And with billions of dollars in bonus payments at stake, it may come as no surprise that stringent standards set out by the Centers for Medicare and Medicaid Services (CMS) have led to plans to push back against agency interpretations and seek judicial redress. We discuss the issues here.</description><pubDate>Wed, 27 Nov 2024 00:00:00 -0600</pubDate><body></body><guid>82b9d8d7-293a-4a91-92c5-0e30774eb3f0</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Healthcare</practice><PGcodes>FDA</PGcodes><author>Tesch Leigh West</author><author>Bryan M. Killian</author></item><item><link>https://www.morganlewis.com/blogs/healthlawscan/2024/10/cms-announces-updated-list-of-drugs-under-the-inflation-rebate-program</link><title>CMS Announces Updated List of Drugs Under the Inflation Rebate Program</title><description>Bipartisan efforts to lower prescription drug costs remains a core focus for the US Congress. Effective October 1, 2024, the Centers for Medicare and Medicaid Services (CMS) has announced the follow-on cohort for its coinsurance savings program under the Medicare Prescription Drug Inflation Rebate Program.</description><pubDate>Wed, 23 Oct 2024 00:00:00 -0500</pubDate><body></body><guid>17032805-c3d3-49c7-97e9-8d6d39923aec</guid><practice>FDA &amp;amp; Healthcare</practice><practice>Healthcare</practice><practice>Life Sciences</practice><PGcodes>FDA</PGcodes><author>Rachel L. Lamparelli</author></item></channel></rss>